Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 2
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
Oncolytic and local immunotherapy
Original research
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
Online download statistics by month:
Online download statistics by month: December 2020 to February 2024
Abstract
Full
Pdf
Dec 2020
308
308
91
Jan 2021
295
295
189
Feb 2021
173
173
99
Mar 2021
181
181
82
Apr 2021
110
110
73
May 2021
122
122
52
Jun 2021
132
132
69
Jul 2021
75
75
55
Aug 2021
88
88
49
Sep 2021
73
73
35
Oct 2021
139
139
98
Nov 2021
118
118
98
Dec 2021
135
135
64
Jan 2022
87
88
60
Feb 2022
63
68
49
Mar 2022
122
123
72
Apr 2022
129
130
53
May 2022
136
139
82
Jun 2022
124
127
89
Jul 2022
114
117
81
Aug 2022
99
102
83
Sep 2022
101
105
64
Oct 2022
114
118
106
Nov 2022
70
70
39
Dec 2022
137
139
61
Jan 2023
150
150
70
Feb 2023
116
116
57
Mar 2023
133
135
73
Apr 2023
76
77
50
May 2023
113
114
57
Jun 2023
102
104
59
Jul 2023
77
77
41
Aug 2023
63
67
34
Sep 2023
96
96
40
Oct 2023
128
128
30
Nov 2023
162
162
45
Dec 2023
54
56
28
Jan 2024
52
53
29
Feb 2024
64
64
41
Total
4631
4674
2547
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?